Platform Technology Partners Gilead Sciences, Inc. Transaction History

Platform Technology Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $225,610 - $243,408	-3,333 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$63.47 - $69.35 $211,545 - $231,143	3,333 New	3,333 $230,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $279,681 - $318,683	-4,937 Closed	0 $0
Q3 2020 Nov 30, 2020	BUY	$62.1 - $78.08 $77,438 - $97,365	1,247 Added 33.79%	4,937 $312,000
Q2 2020 Nov 30, 2020	BUY	$72.34 - $84.0 $266,934 - $309,960	3,690 New	3,690 $284,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

Stay updated on Platform Technology Partners with notifications on news.